FRACTYL HEALTH, INC. (GUTS) Financials
Annual revenue, profitability and per-share results for FRACTYL HEALTH, INC., as reported in SEC filings.
Revenue • FY2025
$0
▼ 100.0%YoY
Net income • FY2025
-$140.95M
▼ 105.2%YoY
Diluted EPS • FY2025
-$1.86
▼ 14.8%YoY
Annual income statement
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $0 | -$140.95M | $0 | -$1.86 | -$90.89M | — | -100.0% |
| FY2024 | $93K | -$68.69M | $43K | -$1.62 | -$67.29M | -100571.0% | -22.5% |
| FY2023 | $120K | -$77.09M | $43K | -$45.29 | -$43.18M | -42363.3% | — |
Figures as reported in FRACTYL HEALTH, INC.'s 10-K filings on SEC EDGAR. Fiscal years may differ from calendar years.
Never miss a GUTS filing.
Get an email when GUTS files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.